Henry Schein ROE 2010-2024 | HSIC

Current and historical return on equity (ROE) values for Henry Schein (HSIC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Henry Schein ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-09-30 $0.32B $4.28B 7.77%
2023-06-30 $0.34B $4.19B 8.09%
2022-12-31 $0.54B $4.10B 12.82%
2022-09-30 $0.64B $4.25B 15.23%
2022-06-30 $0.65B $4.23B 15.64%
2022-03-31 $0.65B $4.22B 15.76%
2021-12-31 $0.63B $4.06B 15.61%
2021-09-30 $0.63B $4.11B 15.58%
2021-06-30 $0.61B $4.01B 15.39%
2021-03-31 $0.44B $4.00B 11.43%
2020-12-31 $0.40B $3.98B 10.77%
2020-09-30 $0.59B $3.79B 16.14%
2020-06-30 $0.59B $3.62B 16.48%
2020-03-31 $0.72B $3.61B 20.25%
2019-12-31 $0.70B $3.63B 19.96%
2019-09-30 $0.50B $3.46B 14.40%
2019-06-30 $0.48B $3.45B 13.86%
2019-03-31 $0.51B $3.42B 15.19%
2018-12-31 $0.54B $3.54B 16.73%
2018-09-30 $0.39B $3.42B 13.02%
2018-06-30 $0.41B $2.92B 14.04%
2018-03-31 $0.41B $2.91B 13.86%
2017-12-31 $0.41B $2.82B 14.03%
2017-09-30 $0.55B $3.02B 19.18%
2017-06-30 $0.55B $2.94B 19.24%
2017-03-31 $0.53B $2.80B 18.65%
2016-12-31 $0.51B $2.80B 17.52%
2016-09-30 $0.50B $2.90B 17.08%
2016-06-30 $0.49B $2.96B 16.82%
2016-03-31 $0.49B $2.92B 16.88%
2015-12-31 $0.48B $2.89B 16.76%
2015-09-30 $0.48B $2.94B 16.97%
2015-06-30 $0.47B $2.87B 16.69%
2015-03-31 $0.47B $2.74B 16.64%
2014-12-31 $0.47B $2.82B 16.48%
2014-09-30 $0.46B $2.82B 16.20%
2014-06-30 $0.45B $2.85B 16.08%
2014-03-31 $0.44B $2.82B 16.13%
2013-12-31 $0.43B $2.79B 16.08%
2013-09-30 $0.42B $2.71B 15.89%
2013-06-30 $0.41B $2.62B 15.71%
2013-03-31 $0.40B $2.58B 15.52%
2012-12-31 $0.39B $2.62B 15.21%
2012-09-30 $0.38B $2.57B 15.20%
2012-06-30 $0.38B $2.49B 15.05%
2012-03-31 $0.37B $2.53B 14.77%
2011-12-31 $0.37B $2.43B 14.68%
2011-09-30 $0.36B $2.54B 14.23%
2011-06-30 $0.35B $2.58B 14.32%
2011-03-31 $0.34B $2.45B 14.36%
2010-12-31 $0.33B $2.41B 14.11%
2010-09-30 $0.32B $2.37B 14.20%
2010-06-30 $0.33B $2.27B 15.04%
2010-03-31 $0.32B $2.19B 14.70%
2009-12-31 $0.31B $2.16B 14.71%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $9.184B $12.339B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00